Chicago, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The global viral vectors & plasmid DNA manufacturing market was valued at 4.21 billion in 2024 and is expected to reach US$ 20.30 billion by 2033, growing at ...

DUBLIN--(BUSINESS WIRE)--The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for the viral vectors ...

Allied Market Research published a report, titled, "Viral Vectors and Plasmid DNA Manufacturing Market by Product (Plasmid DNA, Viral ...

Astute Analytica released an extensive market assessment report titled “Global Viral vectors & plasmid DNA manufacturing market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033.” ...

This study is led by Prof. Qunxin She (Shandong University) and Dr. Guanhua Yuan (Shandong University). The research group has constructed versatile genetic tools for Saccharolobus islandicus REY15A, ...

The global viral vectors & plasmid DNA manufacturing market size is expanding over US$ 1.3 billion by 2027, according to new study by Precedence Research. OTTAWA, Sept. 30, 2020 (GLOBE NEWSWIRE) -- ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026" report to their offering. The "Viral Vectors and Plasmid ...

The MarketWatch News Department was not involved in the creation of this content. Viral Vectors and Plasmid DNA Manufacturing Market to Reach $34.0 billion by 2033 at 20.4% CAGR: Allied Market ...

(MENAFN- GlobeNewsWire - Nasdaq) The surge is fueled by a rapidly expanding gene and cell therapy pipeline, with over 4,000 therapies in development and more than 2,000 active clinical trials ...